Dr. Subedi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
593 Eddy Street
Providence, RI 02903
Education & Training
- OtherClass of 2009
Certifications & Licensure
- RI State Medical License 2013 - 2026
- MA State Medical License 2018 - 2021
- NH State Medical License 2016 - 2020
- PA State Medical License 2014 - 2014
- MI State Medical License 2010 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Clinical Trials
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2022 Apr 18
Roles: Principal Investigator
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Apr 30
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsUstekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing.Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger
Intestinal Research. 2024-07-01 - An Adolescent with Undiagnosed Ulcerative Colitis Presenting with Toxic Megacolon and Cavitary Pulmonary Nodules.Rahiya Rehman, Stephanie Camhi, Jason Shapiro, Shova Subedi, Linda Shalon
Rhode Island Medical Journal. 2024-01-04 - Safety and Durability of Accelerated Infliximab Dosing Strategies in Pediatric IBD: A Single Center, Retrospective Study.Meghan Gibson, Shova Subedi, David H Barker, Samuel Masur, Meaghan M Mallette
Journal of Pediatric Gastroenterology and Nutrition. 2023-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: